Rhythm Pharmaceuticals is a global, commercial-stage biopharmaceutical company focused on rare neuroendocrine diseases. Its lead product, IMCIVREE (setmelanotide), is an MC4R agonist approved in the U.S., EU, UK, Canada, and other countries for treating obesity caused by Bardet-Biedl syndrome and certain genetic MC4R pathway deficiencies. The company also develops two investigational MC4R agonists: bivamelagon (oral) and RM-718 (weekly subcutaneous), targeting hypothalamic obesity, Prader-Willi syndrome, and rare genetic MC4R pathway diseases.
expected 2027-02-02
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001628280-26-012399 | EDGAR | 118K words |
| 2025-02-28 | 2024-12-31 | 0001558370-25-001889 | EDGAR | 122K words |
| 2024-02-29 | 2023-12-31 | 0001558370-24-002181 | EDGAR | 115K words |
| 2023-03-01 | 2022-12-31 | 0001558370-23-002613 | EDGAR | 109K words |
| 2022-03-01 | 2021-12-31 | 0001558370-22-002543 | EDGAR | 105K words |
| 2021-03-01 | 2020-12-31 | 0001558370-21-002121 | EDGAR | 98K words |
| 2020-03-02 | 2019-12-31 | 0001558370-20-001896 | EDGAR | 116K words |
| 2019-03-08 | 2018-12-31 | 0001558370-19-001698 | EDGAR | 118K words |
| 2018-03-12 | 2017-12-31 | 0001558370-18-001923 | EDGAR | 104K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-11-03 | 2026-09-30 | 0001628280-26-069485 | EDGAR | 71K words |
| 2026-08-04 | 2026-06-30 | 0001628280-26-052533 | EDGAR | 70K words |
| 2025-11-04 | 2025-09-30 | 0001104659-25-106264 | EDGAR | 74K words |
| 2025-08-05 | 2025-06-30 | 0001558370-25-010302 | EDGAR | 73K words |
| 2025-05-07 | 2025-03-31 | 0001558370-25-006765 | EDGAR | 70K words |
| 2024-11-06 | 2024-09-30 | 0001558370-24-014532 | EDGAR | 73K words |
| 2024-08-06 | 2024-06-30 | 0001558370-24-011101 | EDGAR | 72K words |
| 2024-05-07 | 2024-03-31 | 0001558370-24-007076 | EDGAR | 69K words |
| 2023-11-08 | 2023-09-30 | 0001558370-23-018291 | EDGAR | 66K words |
| 2023-08-01 | 2023-06-30 | 0001558370-23-012739 | EDGAR | 66K words |
| 2023-05-02 | 2023-03-31 | 0001558370-23-007675 | EDGAR | 63K words |
| 2022-11-08 | 2022-09-30 | 0001558370-22-016818 | EDGAR | 66K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-11-03 | 0001628280-26-069106 | EDGAR | 5K words |
| 2026-08-04 | 0001628280-26-052170 | EDGAR | 5K words |
| 2026-04-03 | 0001628280-26-023606 | EDGAR | 1K words |
| 2026-03-26 | 0001628280-26-021414 | EDGAR | 1K words |
| 2026-03-20 | 0001628280-26-019995 | EDGAR | 2K words |
| 2026-03-16 | 0001628280-26-018211 | EDGAR | 2K words |
| 2026-03-02 | 0001104659-26-021801 | EDGAR | 2K words |
| 2026-02-26 | 0001628280-26-011987 | EDGAR | 5K words |
| 2026-01-09 | 0001628280-26-001459 | EDGAR | 6K words |
| 2025-12-19 | 0001104659-25-123108 | EDGAR | 0K words |
164 total filings indexed. 133 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001649904 |
| Ticker | RYTM |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.rhythmtx.com |
| Listed | 2017-10-05 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/RYTM (~200 tokens, structured JSON with cryptographic provenance)